Whether sodium and fluid restriction reduce exacerbations and readmissions for patients with heart failure: An integrative review

K. MacArthur Lindsay , K. Jones Linda

International Journal of Healthcare ›› 2024, Vol. 10 ›› Issue (1) : 1 -9.

PDF (419KB)
International Journal of Healthcare ›› 2024, Vol. 10 ›› Issue (1) : 1 -9. DOI: 10.5430/ijh.v10n1p1
Reviews
research-article

Whether sodium and fluid restriction reduce exacerbations and readmissions for patients with heart failure: An integrative review

Author information +
History +
PDF (419KB)

Abstract

Heart failure (HF) is a chronic medical condition becoming increasingly prevalent around the world. This condition is linked to poor quality of life (QoL) due to the impact it has on patients functional status and mental health. There have been several advancements in the care and management of patients with HF with little change to self-care interventions resulting. Two self-care interventions which are recommended throughout clinical guidelines are sodium and fluid restriction. These are widely used and encouraged through patient education. Research, however, has questioned their validity and demonstrated a lack of evidence on improved outcomes. In order to determine whether changes to current practice is warranted, an integrative review has been completed. The aim is to assess whether these self-care interventions improve outcomes for patients with HF. From this review identified themes include a lack of robust data, the potential harm of interventions, and various outcomes extending beyond HF exacerbations and readmissions. There appears to be a lack of recent data on the impact of a fluid restriction as an independent variable. However, there are noted improvements in a variety of outcomes from both interventions outside of hospital readmissions which demonstrates they are valuable. Given these findings there is not enough evidence to remove restrictions but there are recommendations which can be made to modify current practice. These recommendations include liberalizing sodium and fluid restrictions and making restrictions more specific to the severity of HF for patients going forward.

Keywords

Heart failure / Quality of life / Self-care / Sodium restriction / Fluid restriction / Readmissions

Cite this article

Download citation ▾
K. MacArthur Lindsay, K. Jones Linda. Whether sodium and fluid restriction reduce exacerbations and readmissions for patients with heart failure: An integrative review. International Journal of Healthcare, 2024, 10(1): 1-9 DOI:10.5430/ijh.v10n1p1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Garcia-Garcia A, Alvarez-Sala-Walther LA, Lee HY, et al. Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review. The Korean Journal of Internal Medicine. 2022; 37(1): 37-47. PMid:34482681. https://doi.org/10.3904/kjim.2020.623

[2]

Garcia CG. A literature review of heart failure transitional care interventions. The American Journal of Accountable Care. 2017; 5(3):21-25.

[3]

Rubio R, Palacios B, Varela L, et al. Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: A mixed-methods study. BMJ Open. 2021; 11(12). PMid:34862295. https://doi.org/10.1136/bmjopen-2021-053216

[4]

Ezekowitz JA, Colin-Ramirez E, Ross H, et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUMHF):An international, open-label, randomised, controlled trial. The Lancet. 2022; 399(1033): 1391-1400. PMid:35381194. https://doi.org/10.1016/S0140-6736(22)00369-5

[5]

Machado d’Almeida KS, Rabelo-Silva ER, Souza GC, et al. Aggressive fluid and sodium restriction in decompensated heart failure with preserved ejection fraction: Results from a randomized clinical trial. Nutrition. 2018; 54: 111-117. PMid:29793053. https://doi.org/10.1016/j.nut.2018.02.007

[6]

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ.2021; 372(71).

[7]

Ivey-Miranda JB, Almeida-Gutierrez E, Herrera-Saucedo R, et al. Sodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trial. Cardiology Journal. 2021; 0(0).

[8]

Li Y, Fu B, Qian X. Liberal versus restricted fluid administration in heart failure patients: A systematic review and meta-analysis of randomized trials. International Heart Journal. 2015; 56(2): 192-195.PMid:25740394. https://doi.org/10.1536/ihj.14-288

[9]

Mahtani KR, Heneghan C, Onakpoya I, et al. Reduced salt intake for heart failure: A systematic review. JAMA Internal Medicine. 2018; 178(12): 1693-1700. PMid:30398532. https://doi.org/10.1001/jamainternmed.2018.4673

[10]

Doukky R, Avery E, Mangla A, et al. Impact of dietary sodium restriction on heart failure outcomes. JACC Heart Failure. 2016; 4(1):24-35. PMid:26738949. https://doi.org/10.1016/j.jchf.2015.08.007

[11]

Al-Jundi A, Sakka S. Critical appraisal of clinical research. Journal of Clinical and Diagnostic Research. 2017; 11(5): JE01-JE05.PMid:28658805. https://doi.org/10.7860/JCDR/2017/26047.9942

[12]

Critical Appraisal Skills Programme. Critical appraisal skills programme (CASP) randomized control trial checklist. 2021. Available from: https://casp-uk.net/casp-tools-checklists

[13]

Critical Appraisal Skills Programme. Critical appraisal skills programme (CASP) systematic review checklist. 2018. Available from: https://casp-uk.net/casp-tools-checklists

[14]

Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure. Canadian Journal of Cardiology. 2017; 33(11): 1342-1433. PMid:29111106. https://doi.org/10.1016/j.cjca.2017.08.022

[15]

American Heart Association. Classes of heart failure. 2022. Available from: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure

[16]

Cleveland Clinic. NT-proB-type natriuretic peptide (BNP). 2022. Available from: https://my.clevelandclinic.org/health/diagnostics/16814-nt-prob-type-natriuretic-peptide-bnp

[17]

Nanayakkara S, Kaye DM. Targets for heart failure with preserved ejection fraction. Clinical Pharmacology & Therapeutics. 2017; 102(2): 228-237. PMid:28466986. https://doi.org/10.1002/cpt.723

[18]

McDonald M, Virani S, Chan M, et al. CCS/CHFS Heart failure guidelines update: Defining a new pharmacologic standard of care for heart failure with reduced ejection fraction. Canadian Journal of Cardiology. 2021; 37(4): 531-546. PMid:33827756. https://doi.org/10.1016/j.cjca.2021.01.017

[19]

University of Ottawa Heart Institute. Heart Failure: Aguide for patients and families. 2018. Available from: https://www.ottawaheart.ca/document/heart-failure-guide-patients-and-families

[20]

Jaarsma T, Hill L, Bayes-Genis A, et al. Self-care of heart failure patients: Practical management recommendations from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2021; 23(1): 157-174. PMid:32945600.https://doi.org/10.1002/ejhf.2008

AI Summary AI Mindmap
PDF (419KB)

388

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/